Biondvax Pharmaceuticals Ltd. Appoints Morris C. Laster as Director of the Board
November 30, 2017 at 09:02 pm
BiondVax Pharmaceuticals Ltd. announced that the board of directors of the company has appointed Dr. Morris C. Laster, M.D. as a director of the board. Dr. Laster possesses over 25 years of experience in the Biomed industry, with expertise in identification, evaluation, finance and management of biomedical innovations in both public and private companies. Dr. Laster is a Venture Partner at OurCrowd and is the CEO of Clil Medical Ltd.